Dietary supplement use among patients with chronic kidney disease

• Authors: Marzena Jakimowicz-Tylicka , Michał Chmielewski , Izabella Kuźmiuk-Glembin , Piotr Skonieczny , Grażyna Dijakiewicz , Grażyna Zdrojewska , Bolesław Rutkowski , Leszek Tylicki , Alicja Dębska Ślizień
• Languages of publication: EN

Abstracts

EN

Background. Dietary supplements (DS) are available over the counter, but patients with impaired renal function are specifically at risk for toxicity when consuming certain DS. The aim of this study was to evaluate the prevalence and characteristics of DS use in patients with chronic kidney disease (CKD). Material and methods. A cross-sectional, controlled DS use survey (22 questions) was conducted among 180 CKD patients (stage 1-5, dialysis, kidney transplant), with 60 patients without CKD serving as controls. Results. DS use did not differ significantly between subjects with and without CKD, unless the CKD patients were on dialysis. In the CKD group, 20% admitted to use DS regularly and 22% did not take the mat all. In the controls, DS consumption was 17% and 13%, respectively (NS). The DS use was higher among women ascompared to men (89% vs. 70%; p < 0.005), and people living in cities versus those living in the country side (81% vs. 63%; p < 0.05). DS most commonly used were: vitamins, minerals, and herbs. Major indications for DS use included: musculoskeletal issues, general health improvement and prevention of urinary tract infections. Subgroup analyses revealed that dialysis patients were characterized by a significantly higher DS use in comparison to CKD stage 1-5 subjects and renal transplant recipients. The decision to introduce DS was made by the physician in 54% of cases; by a pharmacist in 9% of cases, and by the patients themselves in 37%. Only 21% of patients with CKD, and 27% of subjects without CKD, declared knowledge of any possible side-effects associated with DS (NS). Conclusions. The use of DS among patients with CKD is similar to patients without CKD, with the exception of those on dialysis. Vitamins and minerals were the most commonly reported DS consumed. The knowledge on potential side-effectof DS was limited to approximately one-fourth of those surveyed.

Keywords

EN

dietary supplements; vitamins; minerals; chronic kidney disease; dialysis; toxicity

• Publisher: Polish Biochemical Society
• Journal: Acta Biochimica Polonica
• Year: 2018
• Volume: 65
• Issue: 2
• Pages: 319-324

Dates

published

2018

received

2018-02-21

revised

2018-04-10

accepted

2018-04-25

(unknown)

2018-05-30

Contributors

author

Marzena Jakimowicz-Tylicka

• Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdańsk, Poland

author

Michał Chmielewski

• Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdańsk, Poland

author

Izabella Kuźmiuk-Glembin

• Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdańsk, Poland

author

Piotr Skonieczny

• Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdańsk, Poland

author

Grażyna Dijakiewicz

• Family Medicine Centre, Medical University of Gdansk, Gdańsk, Poland

author

Grażyna Zdrojewska

• Family Medicine Centre, Medical University of Gdansk, Gdańsk, Poland

author

Bolesław Rutkowski

• Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdańsk, Poland

author

Leszek Tylicki

• Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdańsk, Poland

author

Alicja Dębska Ślizień

• Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdańsk, Poland

References

• Bouzidi N, Mekki K, Boukaddoum A, Dida N, Kaddous A, Bouchenak M (2010) Effects of omega-3 polyunsaturated fatty-acid supplementation on redox status in chronic renal failure patients with dyslipidemia. J Ren Nutr 20: 321-328.doi: 10.1053/j.jrn.2010.01.002.
• Bressendorff I, Hansen D, Schou M, Kragelund C, Brandi L (2017) The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale. BMJ Open 7: e016795.doi: 10.1136/bmjopen-2017-016795.
• Brown AC (2017) Kidney toxicity related to herbs and dietary supplements: Online table of case reports. Part 3 of 5 series. Food Chem Toxicol 107: 502-519.doi: 10.1016/j.fct.2016.07.024.
• Chen XW, Sneed KB, Pan SY, Cao C, Kanwar JR, Chew H, Zhou SF (2012) Herb-drug interactions and mechanistic and clinical considerations. Curr Drug Metab 13: 640-651.
• Clase CM, Ki V, Holden RM (2013) Water-soluble vitamins in people with low glomerular filtration rate or on dialysis: a review. Semin Dial 26: 546-567.doi: 10.1111/sdi.12099.
• Espe KM, Raila J, Henze A, Blouin K, Schneider A, Schmiedeke D, Krane V, Pilz S, Schweigert FJ, Hocher B, Wanner C, Drechsler C, German Diabetes and Dialysis Study Investigators (2013) Low plasma α-tocopherol concentrations and adverse clinical outcomes in diabetic hemodialysis patients. Clin J Am Soc Nephrol 8: 452-458.doi: 10.2215/CJN.04880511.
• Felsenfeld AJ, Levine BS, Rodriguez M (2015) Pathophysiology of calcium, phosphorus, and magnesium dysregulation in chronic kidney disease. Semin Dial 28: 564-577.doi: 10.1111/sdi.12411.
• Fortmann SP, Burda BU, Senger CA, Lin JS, Whitlock EP (2013) Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: An updated systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 159: 824-834.doi: 10.7326/0003-4819-159-12-201312170-00729.
• Grodstein F, O'Brien J, Kang JH, Dushkes R, Cook NR, Okereke O, Manson JE, Glynn RJ, Buring JE, Gaziano M, Sesso HD (2013) Long-term multivitamin supplementation and cognitive function in men: a randomized trial. Ann Intern Med 159: 806-814.doi: 10.7326/0003-4819-159-12-201312170-00006.
• Gueye S, Saint-Cricq M, Coulibaly M, Goumri N, Guilbeau-Frugier C, Quentin H, Ged E, Sidi Aly A, Rostaing L (2016) Chronic tubulointerstitial nephropathy induced by glucosamine: a case report and literature review. Clin Nephrol 86: 106-110.
• Irish AB, Viecelli AK, Hawley CM, Hooi LS, Pascoe EM, Paul-Brent PA, Badve SV, Mori TA, Cass A, Kerr PG, Voss D, Ong LM, Polkinghorne KR, Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group (2017) Effect of fish oil supplementation and aspirin use on arteriovenous fistula failure in patients requiring hemodialysis: a randomized clinical trial. JAMA Intern Med 177: 184-193.doi: 10.1001/jamainternmed.2016.8029.
• Jadot I, Decleves AE, Nortier J, Caron N (2017) An integrated view of aristolochic acid nephropathy: update of the literature. Int J Mol Sci 18: doi: 10.3390/ijms18020297.
• Jansen E, Viezeliene D, Beekhof P, Gremmer E, Ivanov L (2016) Tissue-specific effects of vitamin E supplementation. Int J Mol Sci 17: doi: 10.3390/ijms17071166.
• Kara B (2009) Herbal product use in a sample of Turkish patients undergoing haemodialysis. J Clin Nurs 18: 2197- 2205.doi: 10.1111/j.1365-2702.2008.02730.x.
• Lamas GA, Boineau R, Goertz C, Mark DB, Rosenberg Y, Stylianou M, Rozema T, Nahin RL, Lindblad L, Lewis EF, Drisko J, Lee KL, TACT (Trial to Assess Chelation Therapy) Investigators (2013) Oral high-dose multivitamins and minerals after myocardial infarction: a randomized trial. Ann Intern Med 159: 797-805.doi: 10.7326/0003-4819-159-12-201312170-00004.
• Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612.
• National Kidney F (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation classification and stratification. Am J Kidney Dis 39 (2 Suppl 1): S1-266.
• Nowack R, Balle C, Birnkammer F, Koch W, Sessler R, Birck R (2009) Complementary and alternative medications consumed by renal patients in southern Germany. J Ren Nutr 19: 211-219.doi: 10.1053/j.jrn.2008.08.008.
• Tangkiatkumjai M, Boardman H, Praditpornsilpa K, Walker DM (2014) Reasons why Thai patients with chronic kidney disease use or do not use herbal and dietary supplements. BMC Complement Altern Med 14: 473.doi: 10.1186/1472-6882-14-473.
• Vergili-Nelsen JM (2003) Benefits of fish oil supplementation for hemodialysis patients. J Am Diet Assoc 103: 1174-1177. doi: 10.1053/jada.2003.50577.
• Wallace TC, McBurney M, Fulgoni VL 3rd (2014) Multivitamin/mineral supplement contribution to micronutrient intakes in the United States 2007-2010. J Am Coll Nutr 33: 94–102.doi: 10.1080/07315724.2013.846806.
• Wierzejska R, Jarosz M, Siuba M, Rambuszek M (2014) Assessing patients' attitudes towards dietary supplements. Rocz Panstw Zakl Hig 65: 317-323 (in Polish).
• Zdrojewski L, Zdrojewski T, Rutkowski M, Bandosz P, Krol E, Wyrzykowski B, Rutkowski B (2016) Prevalence of chronic kidney disease in a representative sample of the Polish population: results of the NATPOL 2011 survey. Nephrol Dial Transplant 31: 433-439.doi: 10.1093/ndt/gfv369.

Identifiers

DOI

10.18388/abp.2018_2578